• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4594882)   Today's Articles (4743)   Subscriber (49329)
Number Citation Analysis
76
Aguzzi J, Fanelli E, Ciuffardi T, Schirone A, De Leo FC, Doya C, Kawato M, Miyazaki M, Furushima Y, Costa C, Fujiwara Y. Faunal activity rhythms influencing early community succession of an implanted whale carcass offshore Sagami Bay, Japan. Sci Rep 2018;8:11163. [PMID: 30042515 PMCID: PMC6057991 DOI: 10.1038/s41598-018-29431-5] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2017] [Accepted: 07/03/2018] [Indexed: 11/20/2022]  Open
77
Murakami M, Watanabe Y, Edahiro A, Ohara Y, Obuchi S, Kawai H, Kim H, Fujiwara Y, Ihara K, Murakami M, Hirano H. Factors related to dissociation between objective and subjective masticatory function in Japanese community-dwelling elderly adults. J Oral Rehabil 2018;45:598-604. [PMID: 29761827 DOI: 10.1111/joor.12650] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/09/2018] [Indexed: 11/28/2022]
78
Kolberg H, Tomasevic Z, Demetriou G, Von Minckwitz G, Fujiwara Y, Ponomarova O, Tesch H, Santi P, Hanes V. Clinical comparison of the biosimilar ABP 980 and trastuzumab in early breast cancer: Results of the phase 3 LILAC study and justification for extrapolation across approved trastuzumab indications. Eur J Cancer 2018. [DOI: 10.1016/s0959-8049(18)30537-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
79
Koyama T, Kondo S, Shimizu T, Fujiwara Y, Kitano S, Ebata T, Shimomura A, Morizane C, Okusaka T, Yamamoto N. Impact of chronic hepatitis virus infection on the feasibility and efficacy for Asian patients with hepatocellular carcinoma in phase I clinical trials. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy047.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
80
Shimomura A, Ebata T, Koyama T, Iwasa S, Kondo S, Kitano S, Yonemori K, Fujiwara Y, Shimizu T, Yamamoto N. Comparison of model-based dose escalation design with rule-based design of phase I oncology trials. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy047.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
81
Ebata T, Shimomura A, Koyama T, Iwasa S, Kondo S, Kitano S, Yonemori K, Fujiwara Y, Shimizu T, Yamamoto N. Impact by age on dose-limiting toxicities in phase 1 oncology trials of cytotoxic agents and molecular targeted agents. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy047.061] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
82
Motokawa K, Watanabe Y, Edahiro A, Shirobe M, Murakami M, Kera T, Kawai H, Obuchi S, Fujiwara Y, Ihara K, Tanaka Y, Hirano H. Frailty Severity and Dietary Variety in Japanese Older Persons: A Cross-Sectional Study. J Nutr Health Aging 2018;22:451-456. [PMID: 29484361 DOI: 10.1007/s12603-018-1000-1] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
83
Nakagawa A, Iwaki M, Kandori H, Kondo H, Yonezawa Y, Takano Y, Arima H, Fujiwara Y, Takeshita K, Okamura Y. Structural insight of zinc binding of Hv1/VSOP in resting state. Acta Crystallogr A Found Adv 2017. [DOI: 10.1107/s2053273317094207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]  Open
84
Tamura N, Horinouchi H, Sekine K, Matsumoto Y, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Ohe Y. Efficacy of subsequent cytotoxic chemotherapy after nivolumab for patients with advanced non-small cell lung cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx671.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
85
Seo T, Shimoi T, Hamada A, Shimomura A, Sudo K, Noguchi E, Yonemori K, Shimizu C, Fujiwara Y, Tamura K. The frequency of somatic AKT1 mutation among Japanese breast and endometrial cancer patients. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx653.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
86
Kanda S, Ohe Y, Matsumoto Y, Murakami S, Goto Y, Horinouchi H, Fujiwara Y, Nokihara H, Yamamoto N, Yamamoto T, Tamura T. P2.07-011 Long Follow up from Phase I Study of Nivolumab and Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.11.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
87
Noguchi E, Kuchiba A, Yonemori K, Shibata T, Ushirozawa N, Tamura K, Fujiwara Y. Current situation and problems of ‘drug lag’ for oncology drugs in Japan. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx668.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
88
Shinno Y, Goto Y, Sato J, Morita R, Matsumoto Y, Murakami S, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Ohe Y. P2.03-048 Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
89
Makihara R, Maeda M, Itahashi K, Noda S, Sato J, Murakami S, Goto Y, Kanda S, Fujiwara Y, Horinouchi H, Tsukamoto T, Hashimoto H, Makino Y, Yamamoto N, Ohe Y, Terakado H. Dried plasma spot assay for sunitinib and its active metabolite by high performance liquid chromatography tandem mass spectrometry. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx678.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
90
Ebata T, Shimizu T, Iizumi S, Koyama T, Shimomura A, Iwasa S, Kondo S, Kitano S, Yonemori K, Fujiwara Y, Yamamoto N. Prognostic factors of patients received immunocheckpoint inhibitors in oncology phase 1 trials. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx658.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
91
Ohyanagi F, Okuma Y, Goto Y, Sunami K, Nakahara Y, Kitazono S, Tambo Y, Yanagitani N, Kanda S, Horiike A, Horinouchi H, Fujiwara Y, Nokihara H, Yamamoto N, Nishio M, Ohe Y, Hosomi Y. MA 16.04 Phase II Trial of S-1 Treatment as Palliative-Intent Chemotherapy for Previously Treated Advanced Thymic Carcinoma. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
92
Iizumi S, Shimomura A, Shimoi T, Sudo K, Noguchi E, Yonemori K, Shimizu C, Fujiwara Y, Tamura K. Impact of perioperative fluoropyrimidines on the efficacy of capecitabine in patients with advanced breast cancer: A retrospective study. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx654.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
93
Fujisaki N, Suwazono S, Suehara M, Nakachi R, Kido M, Fujiwara Y, Oshiro S, Tokashiki T, Takashima H. Clinical course of hereditary motor and sensory neuropathy, Okinawa type. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
94
Shibayama A, Sugita K, Narukawa K, Fujiwara Y, Goto H, Shiomi T, Yoshida Y, Yamamoto O. Granuloma annulare can occur on a scar, mimicking sarcoidosis. Clin Exp Dermatol 2017;42:920-921. [PMID: 28929530 DOI: 10.1111/ced.13210] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/19/2017] [Indexed: 02/01/2023]
95
Okuma Y, Goto Y, Ohyanagi F, Sunami K, Nakahara Y, Kitazono S, Tambo Y, Yanagitani N, Kanda S, Horinouchi H, Horiike A, Fujiwara Y, Nokihara H, Yamamoto N, Nishio M, Ohe Y, Hosomi Y. Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx389.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
96
Takahashi S, Fujiwara Y, Matsubara N, Tomomatsu J, Iwasa S, Yamasaki A, Endo C, Yokoyama S, Doi T. Phase 1 study of ipatasertib (AKT inhibitor) for investigating safety, tolerability, pharmacokinetics (PK), efficacy, and biomarkers in Japanese patients (pts) with solid tumors including castration-resistant prostate cancer (CRPC). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx367.028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
97
Saeki T, Mukai H, Ro J, Lin YC, Fujiwara Y, Nagai S, Lee K, Watanabe J, Ohtani S, Kim S, Kuroi K, Tsugawa K, Tokuda Y, Iwata H, Park Y, Yang Y, Nambu Y. A global phase III clinical study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx365.013] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
98
Aogi K, Yonemori K, Takahashi M, Masuda N, Naito Y, Shimizu S, Nakamura R, Yamamoto H, Hamada A, Michimae H, Tamura K, Sukigara T, Nagasaka R, Fujiwara Y. Efficacy and safety of olaparib combined with eribulin in patients with advanced or metastatic triple negative breast cancer (TNBC) previously treated with anthracyclines and taxanes: The final analysis of a Japanese phase I/II trial. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx365.014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
99
Shimomura A, Yonemori K, Masuda N, Aogi K, Takahashi M, Naito Y, Shimizu S, Nakamura R, Hamada A, Michimae H, Hashimoto J, Yamamoto H, Shimizu C, Tamura K, Fujiwara Y. Gene alteration in triple negative breast cancer patients in a phase I/II study of combination therapy with eribulin and olaparib. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx365.045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
100
Shiozaki M, Inoue K, Ishiura J, Chikata Y, Kimura Y, Fukuda K, Tamura H, Fujiwara Y, Suwa S, Sumiyoshi M, Daida H. P4691The utility of a 0-hour/1-hour algorithm in patients with suspected non-ST elevation myocardial infarction in Japan. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4691] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]  Open
PrevPage 4 of 54 123455354Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA